Navigation Links
Sensortech Announces New, Ligament Balancing TKA Smart Insert
Date:2/6/2013

PENDLETON, S.C., Feb. 6, 2013 /PRNewswire/ -- Sensortech Corporation announced advancement of their new, orthopedic knee alignment product, the Force Check Knee Replacement Smart Insert designed for improving total knee arthroplasty (TKA) surgeries.

Incorporating FDA-approved Bluetooth 4 low energy technology, and FDA-approved plastics technology, the Force Check Knee Replacement Smart Insert can readily adapt to all TKA replacement components on the market. The insert will increase TKA profitability through reduced operating and patient recovery times, faster healing times, reduced component wear, superior pain management and fewer revisions.

With FDA approval, Sensortech's technology could also become a "leave in" device, measuring TKA component performance throughout the replacement's operational life. 

 "The new Smart Insert is a patented, superior solution. It provides real time condyle contact pressure (force) as well as contact location and contact patch movement tracking throughout the flexion test—something unique to the market today. We know the demand for this device is there.  Surgeons and medical device manufacturers have been telling us they need our insert," said inventor Dr. Andrew Clark .

To exploit the market value of this device and assist in acquiring a 510K to develop the "leave in" solution, Sensortech is seeking acquisition partner(s).  The company has also positioned their Force Check Knee Replacement Smart Insert device as an initial entry into a line of medical device smart inserts for all types of joint replacement surgeries.  For more information about Sensortech go to www.sensortechknee.com or contact Sensor Tech Corporation at info@sensortechcorp.com, (864) 298-0684.

This press release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties. Actual results for fiscal year 2013 and beyond could differ materially from Sensortech Corporation's current expectations. Factors that could cause Sensortech Corporation's results to differ materially from those expressed in forward-looking statements include: variation in demand and acceptance of products and services, general business and economic conditions beyond Sensortech Corporation's control, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and Sensortech Corporation's success in attracting and retaining key personnel. Sensortech Corporation undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.


'/>"/>
SOURCE Sensortech Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Emerald Logic announces collaboration with Kings College London on quantitative biomarker discovery
2. Uroplasty Announces Executive Changes In US Sales Organization
3. Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information
4. Blue Belt Technologies Announces Hiring of U.S. Commercial Leadership Team
5. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
6. MGC Diagnostics Corporation Announces National Jewish Health Selects the Company as Preferred Provider for Cardiopulmonary Diagnostic Instrumentation
7. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
8. China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing Requirements
9. BD Announces Results for 2013 First Fiscal Quarter
10. Hologic Announces First Quarter Fiscal 2013 Operating Results
11. Cyberonics Announces Update On Hagerty Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
(Date:5/3/2016)... Research and Markets has announced the addition ... Outlook 2020" report to their offering. ... has improved significantly in past years due to which ... years. Many cancer drugs have been developed by utilization ... expected to be developed with its help. They are ...
(Date:5/3/2016)... 3, 2016  While you may be familiar with watching a film or TV show in ... ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the ... Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
Breaking Medicine Technology:
(Date:5/4/2016)... NY (PRWEB) , ... May 04, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – is set to return to the esteemed Quaker Ridge Golf Club in ...
(Date:5/4/2016)... York, NY (PRWEB) , ... May 04, 2016 ... ... leading private owners, developers and operators of commercial real estate proudly announced that ... 2015 Heart Health initiative. Team members portfolio-wide will continue Olshan Properties’ annual ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... Nurses (WOCN) Society™ and Canadian Association for Enterostomal Therapy (CAET) will be ... saving and planning tools to attendees and exhibitors for the 2016 WOCN Society ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... charity program created to assist the people of their local community. The agency ... organizations and community leaders. Their hope is to bring awareness to important local ...
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow Slepkow & ... one of the top website design companies to create a state of the ... to the law firm's main practice areas. These practice areas include: real estate, ...
Breaking Medicine News(10 mins):